96 related articles for article (PubMed ID: 24076771)
1. Cervical squamocolumnar junction-specific markers define distinct, clinically relevant subsets of low-grade squamous intraepithelial lesions.
Herfs M; Parra-Herran C; Howitt BE; Laury AR; Nucci MR; Feldman S; Jimenez CA; McKeon FD; Xian W; Crum CP
Am J Surg Pathol; 2013 Sep; 37(9):1311-8. PubMed ID: 24076771
[TBL] [Abstract][Full Text] [Related]
2. Performance of specific morphologic features in distinguishing low-grade squamous intraepithelial lesions from high-grade squamous intraepithelial lesions in borderline cases: a College of American Pathologists Cytopathology Committee multiobserver study.
Staats PN; Davey DD; Witt BL; Ghofrani M; Zhao C; Dodd LG; Goodrich K; Husain M; Kurtycz DFI; Russell DK; Shen RZ; Souers RJ; Tabatabai ZL; Crothers BA
J Am Soc Cytopathol; 2022; 11(2):102-113. PubMed ID: 34903496
[TBL] [Abstract][Full Text] [Related]
3. p16 is superior to Stathmin-1 and HSP27 in identifying cervical dysplasia.
Liou S; Nilforoushan N; Kang Y; Moatamed NA
Diagn Pathol; 2021 Sep; 16(1):85. PubMed ID: 34544445
[TBL] [Abstract][Full Text] [Related]
4. MiRNA detection in cervical exfoliated cells for missed high-grade lesions in women with LSIL/CIN1 diagnosis after colposcopy-guided biopsy.
Ye J; Cheng XD; Cheng B; Cheng YF; Chen XJ; Lu WG
BMC Cancer; 2019 Jan; 19(1):112. PubMed ID: 30700264
[TBL] [Abstract][Full Text] [Related]
5. Three-Tiered versus Two-Tiered Classification of Squamous Dysplasia in Cervical Cytology: Results of a Follow-Up Study.
Marquardt K; Ziemke P; Neumann K
Acta Cytol; 2019; 63(1):44-49. PubMed ID: 30517915
[TBL] [Abstract][Full Text] [Related]
6. The value of Ki67 for the diagnosis of LSIL and the problems of p16 in the diagnosis of HSIL.
Liu J; Su S; Liu Y
Sci Rep; 2022 May; 12(1):7613. PubMed ID: 35534530
[TBL] [Abstract][Full Text] [Related]
7. Long-term observational approach in women with histological diagnosis of cervical low-grade squamous intraepithelial lesion: an Italian multicentric retrospective cohort study.
Ciavattini A; Serri M; Di Giuseppe J; Liverani CA; Gardella B; Papiccio M; Delli Carpini G; Morini S; Clemente N; Sopracordevole F
BMJ Open; 2019 Jul; 9(7):e024920. PubMed ID: 31272971
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus DNA, HPV L1 capsid protein and p16
Hu H; Zhao J; Yu W; Zhao J; Wang Z; Jin L; Yu Y; Han L; Wang L; Zhu H; Li F
Arch Gynecol Obstet; 2019 Jan; 299(1):141-149. PubMed ID: 30390110
[TBL] [Abstract][Full Text] [Related]
9. Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology.
Castle PE; Adcock R; Cuzick J; Wentzensen N; Torrez-Martinez NE; Torres SM; Stoler MH; Ronnett BM; Joste NE; Darragh TM; Gravitt PE; Schiffman M; Hunt WC; Kinney WK; Wheeler CM; ;
Arch Pathol Lab Med; 2020 Jun; 144(6):725-734. PubMed ID: 31718233
[TBL] [Abstract][Full Text] [Related]
10. Expression of p16 and HPV E4 on biopsy samples and methylation of FAM19A4 and miR124-2 on cervical cytology samples in the classification of cervical squamous intraepithelial lesions.
Leeman A; Jenkins D; Del Pino M; Ordi J; Torné A; Doorbar J; Meijer CJLM; van Kemenade FJ; Quint WGV
Cancer Med; 2020 Apr; 9(7):2454-2461. PubMed ID: 32022461
[TBL] [Abstract][Full Text] [Related]
11. Classifying Anal Intraepithelial Neoplasia 2 Based on LAST Recommendations.
Liu Y; McCluggage WG; Darragh TM; Zheng W; Roberts JM; Park KJ; Hui P; Blakely M; Sigel K; Gaisa MM
Am J Clin Pathol; 2021 May; 155(6):845-852. PubMed ID: 33210115
[TBL] [Abstract][Full Text] [Related]
12. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
13. Hierarchical evaluation of histology and p16-labeling can improve the risk assessment on cervical intraepithelial neoplasia progression.
Medeiros FS; Dos Santos Gomes FO; Paiva LA; da Silva NCH; da Silva MC; Rygaard MCV; Peixoto CA; Welkovic S; Menezes MLB; Cokan A; Diniz GTN; Donadi EA; Lucena-Silva N
Exp Mol Pathol; 2022 Feb; 124():104734. PubMed ID: 34914974
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical staining of podoplanin is helpful in determining the microinvasion of cervical squamous cell carcinoma.
Qiao X; Sun Y; Zou Y; Lin J; Xu W; Zong Y; Guan X; Zhang R; Wang X
Ann Diagn Pathol; 2020 Jun; 46():151493. PubMed ID: 32179442
[TBL] [Abstract][Full Text] [Related]
15. Association Between Vulvar Squamous Intraepithelial Lesions and Psychiatric Illness.
Bell SG; Kobernik EK; Haefner HK; Welch KC
J Low Genit Tract Dis; 2021 Jan; 25(1):53-56. PubMed ID: 33181537
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Ki67 index and P16 expression in different grades of cervical squamous intraepithelial lesions.
Hosseini MS; Talayeh M; Afshar Moghaddam N; Arab M; Farzaneh F; Ashrafganjoei T
Caspian J Intern Med; 2023; 14(1):69-75. PubMed ID: 36741489
[TBL] [Abstract][Full Text] [Related]
17. Squamocolumnar junction visibility, age, and implications for cervical cancer screening programs.
Desai KT; Hansen N; Rodriguez AC; Befano B; Egemen D; Gage JC; Wentzensen N; Lopez C; Jeronimo J; de Sanjose S; Schiffman M
Prev Med; 2024 Mar; 180():107881. PubMed ID: 38286273
[TBL] [Abstract][Full Text] [Related]
18. The Immunohistochemical Expression of Epithelial-Mesenchymal Transition Markers in Precancerous Lesions and Cervical Cancer.
Popiel-Kopaczyk A; Piotrowska A; Sputa-Grzegrzolka P; Smolarz B; Romanowicz H; Dziegiel P; Podhorska-Okolow M; Kobierzycki C
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175770
[TBL] [Abstract][Full Text] [Related]
19. Rapid, high-resolution, non-destructive assessments of metabolic and morphological homogeneity uniquely identify high-grade cervical precancerous lesions.
Polleys CM; Singh P; Thieu HT; Genega EM; Jahanseir N; Zuckerman AL; Díaz FR; Patra A; Beheshti A; Georgakoudi I
bioRxiv; 2024 May; ():. PubMed ID: 38798665
[TBL] [Abstract][Full Text] [Related]
20. Squamocolumnar junction visibility among cervical cancer screening population in Peru might influence upper age for screening programs.
Lopez-Ampuero C; Hansen N; Alvarez Larraondo M; Taipe-Quico R; Cerna-Ayala J; Desai K; Egemen D; Schiffman M; Jeronimo J
Prev Med; 2023 Sep; 174():107596. PubMed ID: 37451555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
